The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $164.88

Today's change-0.79 -0.48%
Updated July 25 9:55 AM EDT. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $164.88

Today's change-0.79 -0.48%
Updated July 25 9:55 AM EDT. Delayed by at least 15 minutes.

Reversal following new 100-day high

Amgen Inc is lower today, dropping (U.S.)$0.79 or 0.48% to (U.S.)$164.88 after setting a new 100-day high. Over the last five days, shares have gained 1.20%, but are currently unchanged over the last year to date. Shares have performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $165.70
  • Previous close(U.S.) $165.67
  • High(U.S.) $166.15
  • Low(U.S.) $164.81
  • Bid / Ask(U.S.) $164.85 / (U.S.) $164.89
  • YTD % change+1.57%
  • Volume218,317
  • Average volume (10-day)2,388,683
  • Average volume (1-month)2,986,923
  • Average volume (3-month)2,932,690
  • 52-week range(U.S.) $130.09 to (U.S.) $181.81
  • Beta0.81
  • Trailing P/E17.45×
  • P/E 1 year forward14.83×
  • Forward PEG1.75×
  • Indicated annual dividend(U.S.) $4.00
  • Dividend yield2.43%
  • Trailing EPS(U.S.) $9.45
Updated July 25 9:55 AM EDT. Delayed by at least 15 minutes.

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue5,5275,5365,7235,370
Total other revenue--------
Total revenue5,5275,5365,7235,370
Gross profit4,5094,4654,6894,281
Total cost of revenue1,0181,0711,0341,089
Total operating expense3,1253,5033,3843,294
Selling / general / administrative1,2031,4161,2441,160
Research & development8721,0931,119964
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)27-84681
Other operating expenses, total57-19--
Operating income2,4022,0332,3392,076
Interest income (expense), net non-operating-294-284-282-277
Gain (loss) on sale of assets--------
Other--------
Income before tax2,2581,9132,1921,997
Income after tax1,9001,8001,8631,653
Income tax, total358113329344
Net income1,9001,8001,8631,653
Total adjustments to net income--------
Net income before extra. items1,9001,8001,8631,653
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9001,8001,8631,653
Inc. avail. to common incl. extra. items1,9001,8001,8631,653
Diluted net income1,9001,8001,8631,653
Dilution adjustment--------
Diluted weighted average shares760763764768
Diluted EPS excluding extraordinary itemsvalue per share2.502.362.442.15
Dividends per sharevalue per share1.000.790.790.79
Diluted normalized EPSvalue per share2.532.262.452.24